Literature DB >> 16809007

Orexin A mediation of time spent moving in rats: neural mechanisms.

C M Kotz1, C Wang, J A Teske, A J Thorpe, C M Novak, K Kiwaki, J A Levine.   

Abstract

The brain regulates energy balance and spontaneous physical activity, including both small- and large-motor activities. Neural mediators of spontaneous physical activity are currently undefined, although the amount of time spent in sedentary positions versus standing and ambulating may be important in the energetics of human obesity. Orexin A, a neuropeptide produced in caudal hypothalamic areas and projecting throughout the neuraxis, enhances arousal and spontaneous physical activity. To test the hypothesis that orexin A affects the amount of time spent moving, we injected orexin A (0-1000 pmol) into three orexin projection sites in male Sprague-Dawley rats: hypothalamic paraventricular nucleus, rostral lateral hypothalamic area and substantia nigra pars compacta, and measured spontaneous physical activity. Orexin A affects local GABA release and we co-injected orexin A with a GABA agonist, muscimol, in each brain site. Dopamine signaling is important to substantia nigra function and so we also co-injected a dopamine 1 receptor antagonist (SCH 23390) in the substantia nigra pars compacta. In all brain sites orexin A significantly increased time spent vertical and ambulating. Muscimol significantly and dose-dependently inhibited orexin A effects on time spent moving only when administered to the rostral lateral hypothalamic area. In the substantia nigra pars compacta, SCH 23390 completely blocked orexin A-induced ambulation. These data indicate that orexin A influences time spent moving, in three brain sites utilizing separate signaling mechanisms. That orexin A modulation of spontaneous physical activity occurs in brain areas with multiple roles indicates generalization across brain site, and may reflect a fundamental mechanism for enhancing activity levels. This potential for conferring physical activity stimulation may be useful for inducing shifts in time spent moving, which has important implications for obesity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809007     DOI: 10.1016/j.neuroscience.2006.05.028

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  41 in total

1.  Energy expenditure in obesity-prone and obesity-resistant rats before and after the introduction of a high-fat diet.

Authors:  Matthew R Jackman; Paul S MacLean; Daniel H Bessesen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-08-04       Impact factor: 3.619

Review 2.  Energy expenditure: role of orexin.

Authors:  Jennifer A Teske; Vijayakumar Mavanji
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

Review 3.  Sarcopenia: diagnosis and treatment.

Authors:  J E Morley
Journal:  J Nutr Health Aging       Date:  2008 Aug-Sep       Impact factor: 4.075

4.  Spontaneous activity, economy of activity, and resistance to diet-induced obesity in rats bred for high intrinsic aerobic capacity.

Authors:  Colleen M Novak; Carlos Escande; Paul R Burghardt; Minzhi Zhang; Maria Teresa Barbosa; Eduardo N Chini; Steven L Britton; Lauren G Koch; Huda Akil; James A Levine
Journal:  Horm Behav       Date:  2010-03-27       Impact factor: 3.587

Review 5.  Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment.

Authors:  D S Bond; J Roth; J M Nash; R R Wing
Journal:  Obes Rev       Date:  2011-05       Impact factor: 9.213

6.  Behavioral responses to orexin, orexin receptor gene expression, and spontaneous physical activity contribute to individual sensitivity to obesity.

Authors:  Claudio E Perez-Leighton; Kelsey Boland; Jennifer A Teske; Charles Billington; Catherine M Kotz
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-07-24       Impact factor: 4.310

7.  ATP-sensitive potassium channels mediate the thermosensory response of orexin neurons.

Authors:  Matthew P Parsons; Natasha Belanger-Willoughby; Victoria Linehan; Michiru Hirasawa
Journal:  J Physiol       Date:  2012-07-16       Impact factor: 5.182

8.  The effect of clomipramine on wake/sleep and orexinergic expression in rats.

Authors:  P Feng; Y Hu; D Li; D Vurbic; H Fan; S Wang; K P Strohl
Journal:  J Psychopharmacol       Date:  2008-06-18       Impact factor: 4.153

9.  Muscimol microinjection into cerebellar fastigial nucleus exacerbates stress-induced gastric mucosal damage in rats.

Authors:  Jin-zhou Zhu; Su-juan Fei; Jian-fu Zhang; Sheng-ping Zhu; Zhang-bo Liu; Ting-ting Li; Xiao Qiao
Journal:  Acta Pharmacol Sin       Date:  2012-12-17       Impact factor: 6.150

10.  Low Dopamine D2 Receptor Increases Vulnerability to Obesity Via Reduced Physical Activity, Not Increased Appetitive Motivation.

Authors:  Jeff A Beeler; Rudolf P Faust; Susie Turkson; Honggang Ye; Xiaoxi Zhuang
Journal:  Biol Psychiatry       Date:  2015-07-26       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.